Fungal chitin treatment reestablishes the anaerobic bacteria and decreases the intestinal inflammation in mice
Prognostic factors for PM/DM-ILD. A dilemma of treatment intensity?
Analyzing the past to understand the future of anti-obesity therapeutics
Sleep deprivation disrupts visual scanning for driving
Stress induced Eh jumps are caused by sulfide efflux from Escherichia coli cells
Inflammatory Bowel Disease: medical vs surgical vs “sociological” treatments
The human gut continuously hosts an excess of white blood cells in its wall thickness, this lingering inflammation serving to protect us from the outer world that uses the gut as an invading pathway. Unchecked gut inflammation
Statins: Good for the heart, but do they impact the brain?
Risk of non-alcoholic fatty liver disease in patients with type-1 diabetes
Not frozen in time: the past matters to the relationship between body weight and insulin
Lipid membrane nanosensors for environmental monitoring
Butyrate enhances mitochondria respiration when challenged with oxidative stress
Arthropod-specific viruses: where did they come from, what are they doing and where are they going?
Among the hundreds of arthropod-borne viruses (arboviruses), some, for example dengue, West Nile, and yellow fever, cause significant human infections. Millions of infections with symptoms ranging from mild fever to fatal encephalitis occur annually. The suffering is
Healthy commuting – exposure to particulate matter using different transport modes
Hypertrophic scarring: the rabbit ear model for studying dermal fibrosis
Compounded medication for patients with rare diseases
Pharmaceutical compounding is the preparation of unlicensed medicines in order to meet specific patient needs that do not have a licensed (commercial) medicine available on the market. Especially for patients with rare diseases it is complementary when































